Literature DB >> 6689688

Binding characteristics and interactions of depressant drugs with [35S]t-butylbicyclophosphorothionate, a ligand that binds to the picrotoxinin site.

R Ramanjaneyulu, M K Ticku.   

Abstract

[35S]t-Butylbicyclophosphorothionate (TBPT), a cage convulsant with picrotoxinin-like activity, binds to rat brain membranes to a single site with an apparent KD of 25.1 +/- 5.6 nM and a Bmax of 1.40 +/- 0.22 pmol/mg protein. TBPT binding to rat brain membranes was inhibited by a variety of convulsant, depressant, anxiolytic, and anticonvulsant drugs that had previously been shown to inhibit [3H]alpha-dihydropicrotoxinin binding. Depressant drugs such as pentobarbital and the nonbarbiturate (+)etomidate inhibited TBPT binding in an uncompetitive manner. Thus, pentobarbital and (+)etomidate decreased both the affinity and the number of binding sites of TBPT to whole brain membranes. The IC50 values of (+)etomidate (9 microM) and pentobarbital (90 microM) are similar to the EC50 values at which they enhance both [3H]gamma-aminobutyric acid and [3H]diazepam binding in cerebral cortex membranes. RO5-4864, which has recently been shown to be a convulsant, also inhibited TBPT binding (IC50 = 10 microM). These results suggest that TBPT binds to the picrotoxinin site and further supports the notion that the picrotoxinin site is an important modulatory site at the benzodiazepine-GABA receptor-ionophore complex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6689688     DOI: 10.1111/j.1471-4159.1984.tb09721.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

1.  Affinities of barbiturates for the GABA-receptor complex and A1 adenosine receptors: a possible explanation of their excitatory effects.

Authors:  M J Lohse; S Böser; K N Klotz; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

2.  Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes.

Authors:  P D Suzdak; R D Schwartz; P Skolnick; S M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity?

Authors:  D N Stephens; B S Meldrum; R Weidmann; C Schneider; M Grützner
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Interactions of the imidazodiazepine Ro 15-4513 with chemical convulsants.

Authors:  R G Lister; D J Nutt
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

5.  The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers.

Authors:  D Allen; H V Curran; M Lader
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Protection against the lethal effects of pentobarbital in mice by a benzodiazepine receptor inverse agonist, 6,7-dimethoxy-4-ethyl-3-carbomethoxy-beta-carboline.

Authors:  H Havoundjian; G F Reed; S M Paul; P Skolnick
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Effects of pentylenetetrazol on GABA-A/benzodiazepine/picrotoxinin receptor complexes in rat brain regions.

Authors:  M Ito; T H Chiu; H C Rosenberg
Journal:  Neurochem Res       Date:  1986-05       Impact factor: 3.996

8.  The effects of drugs acting at the GABAA-receptor/ionophore after chemical kindling with the benzodiazepine receptor ligand FG 7142.

Authors:  H J Little; D J Nutt; S C Taylor
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

9.  Toxicity of chlorinated bornane (toxaphene) residues isolated from Great Lakes lake trout (Salvelinus namaycush).

Authors:  J W Gooch; F Matsumura
Journal:  Arch Environ Contam Toxicol       Date:  1987-05       Impact factor: 2.804

10.  "In vivo" administration of valproate decreases t-[35S]butylbicyclophosphorothionate binding in the rat brain.

Authors:  A Concas; M P Mascia; E Sanna; G Santoro; M Serra; G Biggio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.